{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:44:44Z","timestamp":1762249484913},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,6,28]],"date-time":"2014-06-28T00:00:00Z","timestamp":1403913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s13277-014-2261-x","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T07:54:38Z","timestamp":1403855678000},"page":"9717-9723","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genome-wide screen for serum microRNA expression profile in mfat-1 transgenic mice"],"prefix":"10.1007","volume":"35","author":[{"given":"Zhuo","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijian","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiankun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,28]]},"reference":[{"key":"2261_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000059674","volume":"83","author":"AP Simopoulos","year":"1998","unstructured":"Simopoulos AP. Overview of evolutionary aspects of omega 3 fatty acids in the diet. World Rev Nutr Diet. 1998;83:1\u201311.","journal-title":"World Rev Nutr Diet"},{"key":"2261_CR2","first-page":"67","volume":"56","author":"AP Simopoulos","year":"2003","unstructured":"Simopoulos AP. Essential fatty acids in health and chronic diseases. Forum Nutr. 2003;56:67\u201370.","journal-title":"Forum Nutr"},{"key":"2261_CR3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10555-012-9401-9","volume":"32","author":"JX Kang","year":"2013","unstructured":"Kang JX, Liu A. The role of the tissue omega-6\/omega-3 fatty acid ratio in regulating tumor angiogenesis. Cancer Metastasis Rev. 2013;32:201\u201310.","journal-title":"Cancer Metastasis Rev"},{"key":"2261_CR4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1017\/S0007114508025798","volume":"101","author":"A Saedisomeolia","year":"2009","unstructured":"Saedisomeolia A, Wood LG, Garg ML, Gibson PG, Wark PA. Anti-inflammatory effects of long-chain n-3 pufa in rhinovirus-infected cultured airway epithelial cells. Br J Nutr. 2009;101:533\u201340.","journal-title":"Br J Nutr"},{"key":"2261_CR5","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.2337\/db10-0054","volume":"59","author":"PJ White","year":"2010","unstructured":"White PJ, Arita M, Taguchi R, Kang JX, Marette A. Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. Diabetes. 2010;59:3066\u201373.","journal-title":"Diabetes"},{"key":"2261_CR6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/carcin\/bgr049","volume":"32","author":"KH Weylandt","year":"2011","unstructured":"Weylandt KH, Krause LF, Gomolka B, et al. Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced tnf-alpha. Carcinogenesis. 2011;32:897\u2013903.","journal-title":"Carcinogenesis"},{"key":"2261_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2008.05.016","volume":"20","author":"C Boudrault","year":"2009","unstructured":"Boudrault C, Bazinet RP, Ma DW. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer\u2019s disease. J Nutr Biochem. 2009;20:1\u201310.","journal-title":"J Nutr Biochem"},{"key":"2261_CR8","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1017\/S0007114511006519","volume":"108","author":"SP Lee","year":"2012","unstructured":"Lee SP, Dart AM, Walker KZ, et al. Effect of altering dietary n-6:N-3 pufa ratio on cardiovascular risk measures in patients treated with statins: a pilot study. Br J Nutr. 2012;108:1280\u20135.","journal-title":"Br J Nutr"},{"key":"2261_CR9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","volume":"142","author":"DY Oh","year":"2010","unstructured":"Oh DY, Talukdar S, Bae EJ, et al. Gpr120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010;142:687\u201398.","journal-title":"Cell"},{"key":"2261_CR10","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhang Y, Jia C, et al. Mtorc1\/2 targeted by n-3 polyunsaturated fatty acids in the prevention of mammary tumorigenesis and tumor progression. Oncogene. 2013. doi: 10.1038\/onc.2013.402 .","journal-title":"Oncogene"},{"key":"2261_CR11","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1073\/pnas.94.4.1142","volume":"94","author":"JP Spychalla","year":"1997","unstructured":"Spychalla JP, Kinney AJ, Browse J. Identification of an animal omega-3 fatty acid desaturase by heterologous expression in arabidopsis. Proc Natl Acad Sci U S A. 1997;94:1142\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2261_CR12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/427504a","volume":"427","author":"JX Kang","year":"2004","unstructured":"Kang JX, Wang J, Wu L, Kang ZB. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature. 2004;427:504.","journal-title":"Nature"},{"key":"2261_CR13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/db09-0284","volume":"59","author":"D Wei","year":"2010","unstructured":"Wei D, Li J, Shen M, et al. Cellular production of n-3 pufas and reduction of n-6-to-n-3 ratios in the pancreatic beta-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death. Diabetes. 2010;59:471\u20138.","journal-title":"Diabetes"},{"key":"2261_CR14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jnutbio.2010.03.003","volume":"22","author":"C Gravaghi","year":"2011","unstructured":"Gravaghi C, La Perle KM, Ogrodwski P, et al. Cox-2 expression, pge(2) and cytokines production are inhibited by endogenously synthesized n-3 pufas in inflamed colon of fat-1 mice. J Nutr Biochem. 2011;22:360\u20135.","journal-title":"J Nutr Biochem"},{"key":"2261_CR15","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/db10-0901","volume":"60","author":"J Bellenger","year":"2011","unstructured":"Bellenger J, Bellenger S, Bataille A, et al. High pancreatic n-3 fatty acids prevent stz-induced diabetes in fat-1 mice: inflammatory pathway inhibition. Diabetes. 2011;60:1090\u20139.","journal-title":"Diabetes"},{"key":"2261_CR16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00232-005-0790-3","volume":"206","author":"JX Kang","year":"2005","unstructured":"Kang JX. From fat to fat-1: a tale of omega-3 fatty acids. J Membr Biol. 2005;206:165\u201372.","journal-title":"J Membr Biol"},{"key":"2261_CR17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11248-011-9554-2","volume":"21","author":"X Wu","year":"2012","unstructured":"Wu X, Ouyang H, Duan B, et al. Production of cloned transgenic cow expressing omega-3 fatty acids. Transgenic Res. 2012;21:537\u201343.","journal-title":"Transgenic Res"},{"key":"2261_CR18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nbt1198","volume":"24","author":"L Lai","year":"2006","unstructured":"Lai L, Kang JX, Li R, et al. Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat Biotechnol. 2006;24:435\u20136.","journal-title":"Nat Biotechnol"},{"key":"2261_CR19","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen X, Ba Y, Ma L, et al. Characterization of micrornas in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997\u20131006.","journal-title":"Cell Res"},{"key":"2261_CR20","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2337\/db07-1252","volume":"57","author":"P Lovis","year":"2008","unstructured":"Lovis P, Roggli E, Laybutt DR, et al. Alterations in microrna expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes. 2008;57:2728\u201336.","journal-title":"Diabetes"},{"key":"2261_CR21","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/carcin\/bgp245","volume":"30","author":"LA Davidson","year":"2009","unstructured":"Davidson LA, Wang N, Shah MS, et al. N-3 polyunsaturated fatty acids modulate carcinogen-directed non-coding microrna signatures in rat colon. Carcinogenesis. 2009;30:2077\u201384.","journal-title":"Carcinogenesis"},{"key":"2261_CR22","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/carcin\/bgs198","volume":"33","author":"CC Mandal","year":"2012","unstructured":"Mandal CC, Ghosh-Choudhury T, Dey N, Choudhury GG, Ghosh-Choudhury N. Mir-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor csf-1 expression. Carcinogenesis. 2012;33:1897\u2013908.","journal-title":"Carcinogenesis"},{"key":"2261_CR23","doi-asserted-by":"crossref","first-page":"e79652","DOI":"10.1371\/journal.pone.0079652","volume":"8","author":"X Chen","year":"2013","unstructured":"Chen X, Liang H, Guan D, et al. A combination of let-7d, let-7\u00a0g and let-7i serves as a stable reference for normalization of serum micrornas. PLoS One. 2013;8:e79652.","journal-title":"PLoS One"},{"key":"2261_CR24","doi-asserted-by":"crossref","first-page":"e26122","DOI":"10.1371\/journal.pone.0026122","volume":"6","author":"H Peurala","year":"2011","unstructured":"Peurala H, Greco D, Heikkinen T, et al. Mir-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer. PLoS One. 2011;6:e26122.","journal-title":"PLoS One"},{"key":"2261_CR25","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1073\/pnas.1101795108","volume":"108","author":"E Tili","year":"2011","unstructured":"Tili E, Michaille JJ, Wernicke D, et al. Mutator activity induced by microrna-155 (mir-155) links inflammation and cancer. Proc Natl Acad Sci U S A. 2011;108:4908\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2261_CR26","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","volume":"122","author":"SH Hsu","year":"2012","unstructured":"Hsu SH, Wang B, Kota J, et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of mir-122 in liver. J Clin Invest. 2012;122:2871\u201383.","journal-title":"J Clin Invest"},{"key":"2261_CR27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2217\/fca.10.19","volume":"6","author":"A Manerba","year":"2010","unstructured":"Manerba A, Vizzardi E, Metra M, Dei Cas L. N-3 pufas and cardiovascular disease prevention. Futur Cardiol. 2010;6:343\u201350.","journal-title":"Futur Cardiol"},{"key":"2261_CR28","doi-asserted-by":"crossref","unstructured":"Stirban A, Nandrean S, Gotting C, Stratmann B, Tschoepe D. Effects of n-3 polyunsaturated fatty acids (pufas) on circulating adiponectin and leptin in subjects with type 2 diabetes mellitus. Horm Metab Res 2013","DOI":"10.1055\/s-0033-1363225"},{"key":"2261_CR29","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3945\/ajcn.112.037432","volume":"96","author":"BK Itariu","year":"2012","unstructured":"Itariu BK, Zeyda M, Hochbrugger EE, et al. Long-chain n-3 pufas reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. Am J Clin Nutr. 2012;96:1137\u201349.","journal-title":"Am J Clin Nutr"},{"key":"2261_CR30","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3945\/ajcn.110.007377","volume":"94","author":"BS Meij van der","year":"2011","unstructured":"van der Meij BS, van Bokhorst-de van der Schueren MA, Langius JA, Brouwer IA, van Leeuwen PA. N-3 pufas in cancer, surgery, and critical care: a systematic review on clinical effects, incorporation, and washout of oral or enteral compared with parenteral supplementation. Am J Clin Nutr. 2011;94:1248\u201365.","journal-title":"Am J Clin Nutr"},{"key":"2261_CR31","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s13277-013-1171-7","volume":"35","author":"W Cao","year":"2014","unstructured":"Cao W, Yang W, Fan R, et al. Mir-34a regulates cisplatin-induce gastric cancer cell death by modulating pi3k\/akt\/survivin pathway. Tumour Biol. 2014;35:1287\u201395.","journal-title":"Tumour Biol"},{"key":"2261_CR32","author":"D Chen","year":"2014","unstructured":"Chen D, Li Y, Mei Y, et al. Mir-34a regulates mesangial cell proliferation via the PDGFR-beta\/Ras-MAPK signaling pathway. Cell Mol Life Sci. 2014. doi: 10.1007\/s00018-014-1599-y .","journal-title":"Cell Mol Life Sci"},{"key":"2261_CR33","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1158\/2159-8290.CD-12-0111","volume":"2","author":"G Genovese","year":"2012","unstructured":"Genovese G, Ergun A, Shukla SA, et al. Microrna regulatory network inference identifies mir-34a as a novel regulator of tgf-beta signaling in glioblastoma. Cancer Discov. 2012;2:736\u201349.","journal-title":"Cancer Discov"},{"key":"2261_CR34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biochi.2013.08.021","volume":"96","author":"Z Zou","year":"2014","unstructured":"Zou Z, Bidu C, Bellenger S, Narce M, Bellenger J. N-3 polyunsaturated fatty acids and her2-positive breast cancer: interest of the fat-1 transgenic mouse model over conventional dietary supplementation. Biochimie. 2014;96:22\u20137.","journal-title":"Biochimie"},{"key":"2261_CR35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2164-11-148","volume":"11","author":"S Liu","year":"2010","unstructured":"Liu S, Li D, Li Q, et al. Micrornas of bombyx mori identified by solexa sequencing. BMC Genomics. 2010;11:148.","journal-title":"BMC Genomics"},{"key":"2261_CR36","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/nar\/gkp1137","volume":"38","author":"PJ Cock","year":"2010","unstructured":"Cock PJ, Fields CJ, Goto N, Heuer ML, Rice PM. The sanger fastq file format for sequences with quality scores, and the solexa\/illumina fastq variants. Nucleic Acids Res. 2010;38:1767\u201371.","journal-title":"Nucleic Acids Res"},{"key":"2261_CR37","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1530\/ERC-12-0394","volume":"20","author":"RL Bitting","year":"2013","unstructured":"Bitting RL, Armstrong AJ. Targeting the pi3k\/akt\/mtor pathway in castration-resistant prostate cancer. Endocr Relat Cancer. 2013;20:R83\u201399.","journal-title":"Endocr Relat Cancer"},{"key":"2261_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/157489210789702208","volume":"5","author":"SE Ghayad","year":"2010","unstructured":"Ghayad SE, Cohen PA. Inhibitors of the pi3k\/akt\/mtor pathway: new hope for breast cancer patients. Recent Pat Anticancer Drug Discov. 2010;5:29\u201357.","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"2261_CR39","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1517\/13543780903321490","volume":"18","author":"HY Yong","year":"2009","unstructured":"Yong HY, Koh MS, Moon A. The p38 mapk inhibitors for the treatment of inflammatory diseases and cancer. Expert Opin Investig Drugs. 2009;18:1893\u2013905.","journal-title":"Expert Opin Investig Drugs"},{"key":"2261_CR40","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1021\/np100228d","volume":"73","author":"V Coothankandaswamy","year":"2010","unstructured":"Coothankandaswamy V, Liu Y, Mao SC, et al. The alternative medicine pawpaw and its acetogenin constituents suppress tumor angiogenesis via the hif-1\/vegf pathway. J Nat Prod. 2010;73:956\u201361.","journal-title":"J Nat Prod"},{"key":"2261_CR41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1349-7006.2007.00430.x","volume":"98","author":"H Toya","year":"2007","unstructured":"Toya H, Oyama T, Ohwada S, et al. Immunohistochemical expression of the beta-catenin-interacting protein b9l is associated with histological high nuclear grade and immunohistochemical erbb2\/her-2 expression in breast cancers. Cancer Sci. 2007;98:484\u201390.","journal-title":"Cancer Sci"},{"key":"2261_CR42","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/j.febslet.2013.09.018","volume":"587","author":"N Zhang","year":"2013","unstructured":"Zhang N, Su Y, Xu L. Targeting pkcepsilon by mir-143 regulates cell apoptosis in lung cancer. FEBS Lett. 2013;587:3661\u20137.","journal-title":"FEBS Lett"},{"key":"2261_CR43","first-page":"753","volume":"5","author":"L Liu","year":"2012","unstructured":"Liu L, Yu X, Guo X, et al. Mir-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting bcl-2. Mol Med Rep. 2012;5:753\u201360.","journal-title":"Mol Med Rep"},{"key":"2261_CR44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.2284","volume":"17","author":"C Liu","year":"2011","unstructured":"Liu C, Kelnar K, Liu B, et al. The microrna mir-34a inhibits prostate cancer stem cells and metastasis by directly repressing cd44. Nat Med. 2011;17:211\u20135.","journal-title":"Nat Med"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2261-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-2261-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2261-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:29:44Z","timestamp":1559489384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-2261-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,28]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["2261"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-2261-x","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,28]]}}}